Medical technology company Capitainer recruits Mathias Karlsson to the role of Chief Medical Officer as part of an initiative to strengthen the team with additional medical expertise. Mathias. Karlsson is a qualified physician and an entrepreneur with solid experience in medical technology, life science and business development. He joins Capitainer from his current role as CEO of Equalis.
Capitainer has developed an innovative technology for self-sampling that could gain significant importance within remote care and precision medicine. The company aims to establish itself as the leading supplier of self-sampling solutions with market-leading clinical accuracy. The company is now taking a key step in this direction by recruiting Mathias Karlsson as Chief Medical Officer (CMO).
Mathias Karlsson is an experienced physician and entrepreneur with a solid background in medical technology and extensive expertise in research and development, life science and business development. Most recently, he comes from a role as CEO of Equalis, an accredited Swedish EQA (external quality assurance) provider for laboratories. Mathias Karlsson has previously held the role of Chief Medical Officer for the Nordics at IBM, with a focus on IT solutions for healthcare services. Prior to this, he was the Head of Outpatient care at the County of Värmland.
He also has solid experience as an entrepreneur within medical technology, having worked with the development and commercialisation of a number of products for person-centred care and as founder of the companies Calmark and Hemcheck.
The recruitment of Mathias Karlsson as CMO further strengthens the medical expertise held by Capitainer while also supplementing the company’s existing technical expertise. The recruitment also expands the company’s network, to enable reaching more operative clinics. Mathias Karlsson will be stepping into the CMO role at Capitainer as of 1 September.
“We’re extremely pleased to be able to welcome Mathias Karlsson to the Capitainer team as our new Chief Medical Officer. His extensive knowledge and expertise within healthcare, diagnostics and medical technology, combined with his experience as an entrepreneur, are exceedingly valuable to Capitainer’s future development,” says Christopher Aulin, CEO of Capitainer.
“I’m really looking forward to joining Capitainer. The company already holds a strong market position, and I believe that its products for self-sampling can be of considerable importance to patients and healthcare personnel as well as within personalised medicine and remote care. My role at Capitainer is to be the patient’s voice in the company’s management team so that we can strive to ensure that Capitainer’s products deliver not only greater precision and accuracy, but also significant value to chronically ill patients, children and the increasingly large elderly population, in a cost-effective manner for healthcare providers,” says Mathias Karlsson.
For more information, please contact:
Christopher Aulin, CEO
Phone: +46 (0)708 977577
Capitainer AB is a Swedish medtech company founded in 2016. Capitainer develops and sells intelligent solutions for self-sampling of blood, plasma, and urine. The company has developed unique technologies for collecting an exact amount of fluid and then allowing it to dry. The sample card can be sent with regular mail to laboratories without needing refrigerated transports or special packaging. The precision and accuracy in Capitainer’s samples are market-leading and perform on the same level as established pipetting methods. The products can be applied within several market segments, for instance, clinical biomarkers, therapeutic drug monitoring, genomics, drug development, drug abuse and doping testing, and R&D and clinical studies.